These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29985715)

  • 1. The Prevention and Therapy of Osteoporosis: A Review on Emerging Trends from Hormonal Therapy to Synthetic Drugs to Plant-Based Bioactives.
    Gupta T; Das N; Imran S
    J Diet Suppl; 2019; 16(6):699-713. PubMed ID: 29985715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.
    Palacios S; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Schenck-Gustafsson K; Tremollieres F; Vujovic S; Rees M; Rozenberg S
    Maturitas; 2012 Feb; 71(2):194-8. PubMed ID: 22176952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The necessity of cost-effectiveness analysis in osteoporosis].
    Lamy O; Krieg MA
    Rev Med Suisse; 2007 Jun; 3(115):1521-5. PubMed ID: 17682796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current views on the interaction between the treatment of osteoporosis and cardiovascular diseases].
    Zapolski T; Wysokiński A
    Wiad Lek; 2016; 69(4):665-674. PubMed ID: 27941208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M; Levancini M
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis.
    Lewiecki EM
    J Womens Health (Larchmt); 2009 Oct; 18(10):1615-26. PubMed ID: 19857095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis prevention and therapy: preserving and building strength through bone quality.
    Kleerekoper M
    Osteoporos Int; 2006 Dec; 17(12):1707-15. PubMed ID: 16909196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison between bisphosphonates and other treatments for osteoporosis.
    Le Goff B; Guillot P; Glémarec J; Berthelot JM; Maugars Y
    Curr Pharm Des; 2010; 16(27):3037-44. PubMed ID: 20722614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Up-to-date treatments for osteoporosis].
    Bors K
    Orv Hetil; 2006 Feb; 147(7):301-6. PubMed ID: 17489157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview on the treatment of postmenopausal osteoporosis.
    Maeda SS; Lazaretti-Castro M
    Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):162-71. PubMed ID: 24830593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.
    Zhang ND; Han T; Huang BK; Rahman K; Jiang YP; Xu HT; Qin LP; Xin HL; Zhang QY; Li YM
    J Ethnopharmacol; 2016 Aug; 189():61-80. PubMed ID: 27180315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anabolic treatment for osteoporosis: PTH treatment].
    Kaji H; Sugimoto T
    Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological agents and natural compounds: available treatments for osteoporosis.
    Martiniakova M; Babikova M; Omelka R
    J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of plant sources on the treatment of osteoporosis.
    Süntar I; Akkol EK
    Curr Drug Targets; 2013 Dec; 14(13):1611-8. PubMed ID: 23978060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective estrogen receptor modulators: A possible new treatment of osteoporosis in males.
    Kastelan D; Giljevic Z; Kraljevic I; Korsic M
    Med Hypotheses; 2006; 67(5):1052-3. PubMed ID: 16790322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety concerns with the long-term management of osteoporosis.
    Reginster JY; Pelousse F; Bruyère O
    Expert Opin Drug Saf; 2013 Jul; 12(4):507-22. PubMed ID: 23614635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-osteoporosis drugs : their characteristics and evidence for anti-fracture efficacy].
    Takeuchi Y
    Clin Calcium; 2012 Jun; 22(6):897-903. PubMed ID: 22653031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review.
    Gallacher SJ; Dixon T
    Calcif Tissue Int; 2010 Dec; 87(6):469-84. PubMed ID: 20872215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].
    Uebelhart D; Frey D; Frey-Rindova P; Goerres G; Michel BA
    Z Rheumatol; 2003 Dec; 62(6):512-7. PubMed ID: 14685711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Present development of new drugs for osteoporosis].
    Wada S
    Clin Calcium; 2006 Jan; 16(1):176-81. PubMed ID: 16397369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.